Skip to main content

NEPHROS INC

For the period ended Dec 31, 2024. Filed Mar 24, 2025.

View on SEC.gov

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2024 · Filed Mar 24, 2025

NEPH$3.15+5.0%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Power of Attorney (included on the signature page). *

POWER OF ATTORNEY

We, the undersigned directors and officers of Nephros, Inc., hereby severally constitute and lawfully appoint Robert Banks, our true and lawful attorney-in-fact with full power to him to sign for us, in our names in the capacities indicated below, the Annual Report on Form 10-K for the fiscal year ended December 31, 2024 of Nephros, Inc. and any and all amendments thereto, and to file the same with all exhibits thereto, and all other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorney-in-fact and agent, full power and authority to do and perform each and every act and thing requisite and necessary to be done, as fully to all intents and purposes as such person might or could do in person, hereby ratifying and confirming all that said attorney-in-fact and agent, or their or his or her substitute or substitutes, may lawfully do or cause to be done by virtue hereof.

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the Registrant and in the capacities and on the dates indicated.

SignatureTitleDate
/s/ Robert BanksPresident, Chief Executive OfficerMarch 24, 2025
Robert Banks(Principal Executive Officer)
/s/ Judy KrandelChief Financial OfficerMarch 24, 2025
Judy Krandel(Principal Financial and Accounting Officer)
/s/ Arthur H. AmronDirectorMarch 24, 2025
Arthur H. Amron
/s/ Oliver SpandowDirectorMarch 24, 2025
Oliver Spandow
/s/ Alisa LaskDirectorMarch 24, 2025
Alisa Lask
/s/Joe HarrisDirectorMarch 24, 2025
Joe Harris
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.